The funding accelerates Earflo's path to regulatory approval and market entry, potentially opening a new, non‑surgical treatment option in the pediatric otology market and demonstrating philanthropic support for health‑tech innovations targeting underserved pediatric needs.
Medical‑tech startup Earflo announced a $415,000 social‑mission investment from the Richard King Mellon Foundation to fund FDA clearance, manufacturing and launch of its at‑home treatment for negative middle ear pressure in children.
Comments
Want to join the conversation?
Loading comments...